John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$175M |
| 2 |
Kroger
KR
|
+$148M |
| 3 |
Elevance Health
ELV
|
+$122M |
| 4 |
EA
Electronic Arts
EA
|
+$120M |
| 5 |
Abbott
ABT
|
+$119M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$181M |
| 2 |
Halliburton
HAL
|
+$152M |
| 3 |
Pfizer
PFE
|
+$145M |
| 4 |
AGN
Allergan plc
AGN
|
+$124M |
| 5 |
AutoZone
AZO
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.33% |
| 2 | Technology | 13.07% |
| 3 | Consumer Discretionary | 10.5% |
| 4 | Financials | 9.32% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
PUT
Hasbro
HAS
$13.6B
| $504K | ﹤0.01% |
+6,000
| New | +$508K |
|
2252
PUT
Lam Research
LRCX
$394B
| $504K | ﹤0.01% |
60,000
-70,000
| -54% | -$562K |
|
2253
CALL
Teva Pharmaceuticals
TEVA
$44.4B
| $502K | ﹤0.01% |
+10,000
| New | +$532K |
|
|
VWTR
2254
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $502K | ﹤0.01% |
53,074
+348
| +0.7% | +$3.34K |
|
|
CRZO
2255
CALL
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $502K | ﹤0.01% |
14,000
+4,000
| +40% | +$143K |
|
|
SBNY
2256
CALL
DELISTED
Signature Bank
SBNY
| $500K | ﹤0.01% |
+4,000
| New | +$534K |
|
2257
PUT
Edwards Lifesciences
EW
$52.4B
| $499K | ﹤0.01% |
+15,000
| New | +$513K |
|
|
TRQ
2258
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $497K | ﹤0.01% |
14,693
-16,051
| -52% | -$466K |
|
2259
PUT
ASML
ASML
$670B
| $496K | ﹤0.01% |
+5,000
| New | +$486K |
|
2260
CALL
Vale
VALE
$65.2B
| $496K | ﹤0.01% |
+98,100
| New | +$459K |
|
2261
Abercrombie & Fitch
ANF
$4.84B
| $493K | ﹤0.01% |
27,696
+4,402
| +19% | +$105K |
|
2262
PUT
Kohl's
KSS
$2B
| $493K | ﹤0.01% |
13,000
+3,000
| +30% | +$119K |
|
|
IQNT
2263
DELISTED
Inteliquent, Inc.
IQNT
| $490K | ﹤0.01% |
24,651
-5,890
| -19% | -$99.6K |
|
|
VMRK
2264
PUT
Vivmark Residential
VMRK
$27B
| $489K | ﹤0.01% |
7,100
+100
| +1% | +$6.88K |
|
|
XCRA
2265
DELISTED
Xcerra Corporation
XCRA
| $489K | ﹤0.01% |
85,017
-28,209
| -25% | -$173K |
|
|
ELOS
2266
DELISTED
Syneron Medical Ltd
ELOS
| $489K | ﹤0.01% |
63,545
+18,375
| +41% | +$131K |
|
|
JAX
2267
DELISTED
J. Alexander's Holdings, Inc.
JAX
| $488K | ﹤0.01% |
49,158
+9,438
| +24% | +$96.3K |
|
|
AEGR
2268
DELISTED
Aegerion Pharmaceuticals
AEGR
| $488K | ﹤0.01% |
327,741
+255,454
| +353% | +$584K |
|
|
SRGA
2269
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $487K | ﹤0.01% |
4,520
-955
| -17% | -$112K |
|
2270
CALL
Deere & Co
DE
$170B
| $486K | ﹤0.01% |
+6,000
| New | +$492K |
|
2271
Huntsman Corp
HUN
$1.67B
| $486K | ﹤0.01% |
36,110
+15,998
| +80% | +$235K |
|
2272
CALL
JB Hunt Transport Services
JBHT
$24.6B
| $486K | ﹤0.01% |
+6,000
| New | +$495K |
|
2273
PUT
Chord Energy
CHRD
$7.7B
| $485K | ﹤0.01% |
+51,900
| New | +$492K |
|
|
CMA
2274
PUT
DELISTED
Comerica
CMA
| $485K | ﹤0.01% |
11,800
-200
| -2% | -$8.53K |
|
2275
CALL
Public Service Enterprise Group
PEG
$36.5B
| $485K | ﹤0.01% |
10,400
-9,600
| -48% | -$436K |
|
Similar funds
John Overdeck's Q2 2016 Portfolio in Review
As of Q2 2016, John Overdeck held 3,523 positions worth $23.3B, up 11% from $21B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
John Overdeck deployed $2B of net new capital in Q2 2016, opening 779 new positions and adding to 1,113 existing holdings. Its largest new stake was Kroger: 4,100,027 shares worth $151M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Pfizer, an estimated $145M trimmed.
- John Overdeck's largest Q2 2016 buy was Kroger: 4,100,027 shares worth $151M.
- John Overdeck added most to Nike in Q2 2016, an estimated $175M increase.
- John Overdeck's biggest Q2 2016 reduction was Pfizer, cutting an estimated $145M.
- John Overdeck fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $181M.
- John Overdeck's ten largest holdings make up 7.4% of its $23.3B portfolio in Q2 2016.
- John Overdeck opened 779 new positions and closed 661 in Q2 2016.
- John Overdeck's portfolio value rose 11% quarter-over-quarter to $23.3B.
Based on Two Sigma Investments's 13F filing for Q2 2016, filed 15 Aug 2016.